Prevalence of metabolic syndrome in an elderly Swedish population.

Department of Geriatric Medicine, Gothenburg University, Gothenburg, Sweden.
Acta Diabetologica (Impact Factor: 4.63). 12/2006; 43(4):120-6. DOI: 10.1007/s00592-006-0226-2
Source: PubMed

ABSTRACT The prevalence of the metabolic syndrome in different elderly European populations has not been well studied. The aim of this study was to measure the prevalence of metabolic syndrome, as well as its individual components, in an elderly Swedish cohort. A random sample of 778 individuals (372 men and 406 women) was selected from a 70-year-old cohort in the H70 study, a gerontological and geriatric population study carried out in Gothenburg, Sweden. The study included medical and treatment history assessments, laboratory procedures and physical examinations to determine the presence of each of the five components of the metabolic syndrome as defined by the National Cholesterol Education Program Adult Treatment Panel III. Of the 508 adults (243 men and 265 women) included in the study, 22.6% had metabolic syndrome. The prevalence was higher in men (26.3%) than in women (19.2%). One third of the total sample had at least one of the five risk factors for metabolic syndrome. High blood pressure (> or =130/85 mmHg or use of antihypertensive/diuretic medication) was the most prevalent risk factor in both men (68.3%) and women (50.2%), while abdominal obesity was the overall second most common risk factor (27.2% of men and 42.7% of women). The prevalence of high fasting plasma glucose (> or =110 mg/dl or use of antidiabetic medication) was 29.0% in men and 19.1% in women. Metabolic syndrome was prevalent in a significant proportion of this elderly Swedish population, highlighting the underdiagnosis of a condition that is important to treat.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Background and objectiveInformation about the prevalence of the metabolic syndrome (MS) in elderly population is scarce. The objectives of this study were to assess the prevalence of MS in Spanish population=60 years-old and the associated factors.
    Medicina Clinica - MED CLIN. 01/2009; 132(5):172-179.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: BACKGROUND: Not all the people with metabolic syndrome (MS) have abdominal obesity (AO). The study aimed to investigate gender differences in the prevalence and development of MS in Chinese population with abdominal obesity, which has rarely been reported. METHODS: Data were obtained from the 2007-08 China National Diabetes and Metabolic Disorders Study, and participants were divided into two samples for analysis. Sample 1 consisted of 19,046 people with abdominal obesity, while sample 2 included 2,124 people meeting pre-specified requirements. Survival analysis was used to analyze the development of MS. RESULTS: The age-standardized prevalence of MS in Chinese population with AO was 49.5%. The prevalence in males (73.7%) was significantly higher than that in females (36.9%). Males had significantly higher proportions of combinations of three or four MS components than females (36.4% vs. 30.2% and 18.4% vs. 5%, respectively). MS developed quick at first and became slow down later. Half of the participants with AO developed to MS after 3.9 years (95% CI: 3.7-4.1) from the initial metabolic abnormal component, whereas 75% developed to MS after 7.7 years (95% CI: 7.5-7.9). CONCLUSION: Compared with females, Chinese males with AO should receive more attention because of their higher prevalence of MS and its components, more complex and risky combinations of abnormal components, and faster development of MS.
    PLoS ONE 01/2013; 8(10):e78270. · 3.53 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Background Polypharmacy is an important concern for patient safety and has been associated with increased adverse drug reactions, hospitalization and mortality in the elderly. Objective In light of the above, the present study aimed to assess the major characteristics associated with polypharmacy (≥ 4 drugs) in a larger population of apparently healthy older subjects over 60 years. Study-Design Cross-sectional study. Setting The preventive medical center (CMP) in Nancy. Participants 2,545 volunteers (1,175 women, 1,370 men) aged 60 years and older (66 ± 4.8 years) were included from the Senior health examination study. Measurements All subjects underwent clinical, biological examinations. Sociodemographic data, practice of regular physical activity and drug intake data were collected. A self-administered questionnaire of health status, psychological status and questions regarding falls were collected. Results The prevalence of polypharmacy in this study was 29.9%. The number of drugs in polymedicated people was 5.67 ± 1.82 versus 1.32 ± 1.11 in non polymedicated people; p≤0.01. Multivariate analyses identified 6 independent variables associated with polypharmacy: age over 65 years (OR = 1.58 95% CI: [1.05–2.38]; p = 0.03), poor self-perceived health status (2.79 [1.80–4.31]; p ≤ 0,01), history of falls (1.66 [1.02–2.71]; p = 0.04), lack of a physical activity (1.50 [1.001–2.26]; p = 0.049), metabolic syndrome (3.17 [1.95–5.15]; p ≤ 0,01), low or medium education level (2.20 [1.24–4.30]; p = 0.02). Conclusion Among community-dwelling people aged 60 years and over, in addition to the presence of several diseases and advanced age, the psychological and socio-educative factors may influence drug intake and polypharmacy in the elderly. Physicians should be take into account these considerations before issuing any prescriptions and review all medications used at every visit to avoid unnecessary addictions or dangerous drugdrug interactions.
    The Journal of Nutrition Health and Aging 01/2014; · 2.39 Impact Factor